It has been shown that high expression of PKM2 in tissues of osteosarcoma patients is associated with poor prognosis, and knockdown of PKM2 can inhibit proliferation and invasion of osteosarcoma cells in vitro and in vivo (18, 19, 20). This evidence concerns the gene PKM and osteosarcoma.